Ganix Nutricare Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 07-07-2024
- Paid Up Capital ₹ 2.80 M
as on 07-07-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets %
(FY 2023)
About Ganix Nutricare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.80 M, as per Ministry of Corporate Affairs (MCA) records.
Satish Saraf and Srikanth Bureddy serve as directors at the Company.
- CIN/LLPIN
U74999DL2017PTC317802
- Company No.
317802
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2017
- Date of AGM
07 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ganix Nutricare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Saraf  | Additional Director | 28-Mar-2018 | Current |
| Srikanth Bureddy | Additional Director | 16-Jan-2018 | Current |
Financial Performance and Corporate Structure Insights of Ganix Nutricare.
Ganix Nutricare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ganix Nutricare?
In 2023, Ganix Nutricare had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Valueleaf Services (India) Private LimitedActive 15 years 8 monthsSatish Saraf and Srikanth Bureddy are mutual person
Wvalue Martech Private LimitedActive 5 years 2 monthsSatish Saraf and Srikanth Bureddy are mutual person
Bvalue Services Private LimitedActive 5 years 3 monthsSatish Saraf and Srikanth Bureddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ganix Nutricare?
Ganix Nutricare has a workforce of 41 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ganix Nutricare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ganix Nutricare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
